🌱 KidneyEnergy.com

← brief for 2026-10-22 · Slowing decline

Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies.

Paper No results yet Peer reviewed

Key takeaways

This review looks at the safety of GLP-1 drugs. It discusses known side effects and myths. It does not report new trial results. There are no new data from this item.

Who did this work

Kounatidis DC · Vallianou NG · Kouveletsou M · Kontrafouri P · Stamatopoulos V · Rebelos E · Diakoumopoulou E · Dalamaga M

Source

Paper · PubMed, the drug frontier · 2026 Oct 21
https://pubmed.ncbi.nlm.nih.gov/42905300/